Results for tag: "Retinal Drug"

The Retinal Drug market is a subset of the Optical Disorders Drugs market, which focuses on treatments for diseases and disorders of the eye. Retinal drugs are used to treat a variety of conditions, including age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion. These drugs are typically administered via intravitreal injections, which are injections directly into the eye. The Retinal Drug market is highly competitive, with a number of companies developing and marketing treatments for these conditions. Some of the major players in the Retinal Drug market include Regeneron Pharmaceuticals, Novartis, Allergan, Bayer, and Roche. These companies have developed a range of treatments for retinal diseases, including anti-VEGF drugs, steroids, and other therapies. Show Less Read more